Mental health care utilization following a new positive PTSD screen in primary care in the Veterans Health Administration

Abstract: Although there is an active screening program for posttraumatic stress disorder (PTSD) in Veterans Health Administration (VHA) primary care clinics and empirically supported treatments for PTSD are available, many patients who are identified through screening and receive a new PTSD diagnosis do not engage in cognitive processing therapy (CPT) or prolonged exposure therapy (PE). CPT and PE are both widely promoted and recommended first-line treatments in the VHA that were the focus of the VHA's initial implementation of evidence-based psychotherapy for PTSD. We examined the mental health care patients received following a new positive PTSD screen in VHA primary care clinics and whether health system factors were associated with engaging in CPT or PE. A national cohort of VHA primary care patients who screened positive for PTSD in 2018 were followed for 1 year from the date of screening. Overall, 20,853 patients screened positive for PTSD; of these, 76% received a diagnostic clinical evaluation, and 86% of these patients evaluated received a confirmatory PTSD diagnosis within 1 year of screening. Ten percent (n = 1,372) of patients who received a confirmatory PTSD diagnosis engaged in CPT or PE. Confirmatory evaluation location (in a PTSD specialty clinic) and timing (within 3 months of screening) were each associated with increased likelihood of engaging in CPT or PE. Most patients who screen positive for PTSD in VHA primary care clinics are connected to follow-up clinical evaluations and receive confirmatory PTSD diagnoses. However, only one-in-ten patients who screen positive and receive a confirmatory PTSD diagnosis go on to receive CPT or PE. Screening appears to more effectively lead to patients with PTSD engaging in CPT or PE when the confirmatory evaluation occurs quickly and in a setting prepared to deliver evidence-based treatment.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.